215 related articles for article (PubMed ID: 8254210)
1. Immunobiologic and biochemical properties of mutants of toxic shock syndrome toxin-1.
Murray DL; Prasad GS; Earhart CA; Leonard BA; Kreiswirth BN; Novick RP; Ohlendorf DH; Schlievert PM
J Immunol; 1994 Jan; 152(1):87-95. PubMed ID: 8254210
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.
Bohach GA; Fast DJ; Nelson RD; Schlievert PM
Crit Rev Microbiol; 1990; 17(4):251-72. PubMed ID: 2206394
[TBL] [Abstract][Full Text] [Related]
3. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome.
Bonventre PF; Heeg H; Cullen C; Lian CJ
Infect Immun; 1993 Mar; 61(3):793-9. PubMed ID: 8432600
[TBL] [Abstract][Full Text] [Related]
4. Nucleotide sequences and biologic properties of toxic shock syndrome toxin 1 from ovine- and bovine-associated Staphylococcus aureus.
Lee PK; Kreiswirth BN; Deringer JR; Projan SJ; Eisner W; Smith BL; Carlson E; Novick RP; Schlievert PM
J Infect Dis; 1992 Jun; 165(6):1056-63. PubMed ID: 1583323
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1.
Miethke T; Duschek K; Wahl C; Heeg K; Wagner H
Eur J Immunol; 1993 Jul; 23(7):1494-500. PubMed ID: 8325325
[TBL] [Abstract][Full Text] [Related]
6. Mutations affecting the activity of toxic shock syndrome toxin-1.
Deresiewicz RL; Woo J; Chan M; Finberg RW; Kasper DL
Biochemistry; 1994 Nov; 33(43):12844-51. PubMed ID: 7947690
[TBL] [Abstract][Full Text] [Related]
7. Structures of five mutants of toxic shock syndrome toxin-1 with reduced biological activity.
Earhart CA; Mitchell DT; Murray DL; Pinheiro DM; Matsumura M; Schlievert PM; Ohlendorf DH
Biochemistry; 1998 May; 37(20):7194-202. PubMed ID: 9585531
[TBL] [Abstract][Full Text] [Related]
8. Co-production of staphylococcal enterotoxin A with toxic shock syndrome toxin-1 (TSST-1) enhances TSST-1 mediated mortality in a D-galactosamine sensitized mouse model of lethal shock.
De Boer ML; Kum WW; Pang LT; Chow AW
Microb Pathog; 1999 Aug; 27(2):61-70. PubMed ID: 10458917
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome.
De Boer ML; Kum WW; Chow AW
Can J Microbiol; 1999 Mar; 45(3):250-6. PubMed ID: 10408098
[TBL] [Abstract][Full Text] [Related]
10. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality.
Kum WW; Laupland KB; Chow AW
Can J Microbiol; 2000 Feb; 46(2):171-9. PubMed ID: 10721486
[TBL] [Abstract][Full Text] [Related]
11. Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1.
Buonpane RA; Moza B; Sundberg EJ; Kranz DM
J Mol Biol; 2005 Oct; 353(2):308-21. PubMed ID: 16171815
[TBL] [Abstract][Full Text] [Related]
12. Effects of total body irradiation and cyclosporin a on the lethality of toxic shock syndrome toxin-1 in a rabbit model of toxic shock syndrome.
Dinges MM; Gregerson DS; Tripp TJ; McCormick JK; Schlievert PM
J Infect Dis; 2003 Oct; 188(8):1142-5. PubMed ID: 14551884
[TBL] [Abstract][Full Text] [Related]
13. Fluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxins.
Lee PK; Deringer JR; Kreiswirth BN; Novick RP; Schlievert PM
Infect Immun; 1991 Mar; 59(3):879-84. PubMed ID: 1997438
[TBL] [Abstract][Full Text] [Related]
14. Toxic shock syndrome--the role of the toxin.
Bergdoll MS; Reiser RF; Crass BA; Robbins RN; Thompson NE
Postgrad Med J; 1985; 61 Suppl 1():35-8. PubMed ID: 3932991
[TBL] [Abstract][Full Text] [Related]
15. Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non-toxic shock syndrome origin.
Bonventre PF; Weckbach L; Harth G; Haidaris C
Rev Infect Dis; 1989; 11 Suppl 1():S90-5. PubMed ID: 2928656
[TBL] [Abstract][Full Text] [Related]
16. Localization of biologic functions of toxic shock syndrome toxin-1 by use of monoclonal antibodies and cyanogen bromide-generated toxin fragments.
Blomster-Hautamaa DA; Novick RP; Schlievert PM
J Immunol; 1986 Dec; 137(11):3572-6. PubMed ID: 3782792
[TBL] [Abstract][Full Text] [Related]
17. Toxic shock syndrome: a multisystem conundrum.
Arbuthnott JP
Microbiol Sci; 1988 Jan; 5(1):13-6. PubMed ID: 3079212
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the early response to TSST-1 reveals Vbeta-unrestricted extravasation, compartmentalization of the response, and unresponsiveness but not anergy to TSST-1.
Waclavicek M; Stich N; Rappan I; Bergmeister H; Eibl MM
J Leukoc Biol; 2009 Jan; 85(1):44-54. PubMed ID: 18923105
[TBL] [Abstract][Full Text] [Related]
19. Effects of toxic shock syndrome Staphylococcus aureus, endotoxin and tampons in a mouse model.
Tierno PM; Malloy V; Matias JR; Hanna BA
Clin Invest Med; 1987 Mar; 10(2):64-70. PubMed ID: 3581548
[TBL] [Abstract][Full Text] [Related]
20. Induction of murine hemopoietic growth factors by toxic shock syndrome toxin-1.
Galelli A; Anderson S; Charlot B; Alouf JE
J Immunol; 1989 Apr; 142(8):2855-63. PubMed ID: 2784816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
